HAVIX FDA Approval ANDA 214089

ANDA 214089

HAVIX

FDA Drug Application

Application #214089

Application Sponsors

ANDA 214089HAVIX

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE;ORAL150MG0MEXILETINE HYDROCHLORIDEMEXILETINE HYDROCHLORIDE
002CAPSULE;ORAL200MG0MEXILETINE HYDROCHLORIDEMEXILETINE HYDROCHLORIDE
003CAPSULE;ORAL250MG0MEXILETINE HYDROCHLORIDEMEXILETINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-10-01STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

HAVIX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214089
            [companyName] => HAVIX
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEXILETINE HYDROCHLORIDE","activeIngredients":"MEXILETINE HYDROCHLORIDE","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEXILETINE HYDROCHLORIDE","activeIngredients":"MEXILETINE HYDROCHLORIDE","strength":"200MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEXILETINE HYDROCHLORIDE","activeIngredients":"MEXILETINE HYDROCHLORIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/01\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-01
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.